BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

RSPHvsFHLCETF Comparison

ETF 1

RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of

US Health Care

-0.56%

Full RSPH fund page

VS

ETF 2

FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of

US Health Care

-0.56%

Full FHLC fund page

Invesco S&P 500® Equal Weight Health Care ETF (RSPH) and Fidelity MSCI Health Care Index ETF (FHLC) belong to the same industry segment: US Health Care. RSPH's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, FHLC's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. RSPH is more expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.084% for FHLC. RSPH is up 26.01% year-to-date (YTD) with +$65M in YTD flows. FHLC performs worse with 19.89% YTD performance, and +$495M in YTD flows. Run a side-by-side ETF comparison of RSPH and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

RSPH vs FHLC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 11/02/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	RSPH FHLC	+8.93%+9.44%	+13.79%+12.25%	+26.01%+19.89%	+32.78%+28.45%	+56.80%+55.41%	+33.66%+40.98%
Flows	RSPH FHLC	+$39M+$34M	+$108M+$227M	+$65M+$495M	+$63M+$559M	-$217M-$149M	-$202M+$72M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	RSPH FHLC	+18.29%+16.71%	+16.88%+16.01%	+15.92%+14.91%	+16.81%+15.52%
Max drawdown	RSPH FHLC	-5.57%-5.64%	-10.87%-10.35%	-16.96%-16.88%	-21.91%-17.78%
Max drawdown duration	RSPH FHLC	55d56d	116d169d	434d435d	817d762d

Trading data

Create an account to view trading data

Join for free

	RSPH	FHLC
Last sale 11/3/2026 at 5:20 PM	$40.14	$88.70
Previous close 11/02/2026	$39.90	$88.24
Consolidated volume 11/02/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of October 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	RSPH	FHLC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 11/3/2026 at 5:20 PM

Live

Closed

	RSPH	FHLC
Last price	$40.14	$88.70
1D performance	+0.60%	+0.52%
AuM	$992.08 M	$3.94 B
E/R	0.4%	0.084%

Characteristics

	RSPH	FHLC
Management strategy	Passive	Passive
Provider	Invesco	Fidelity
Benchmark	S&P 500 Equal Weight Health Care Index	MSCI USA IMI Health Care 25/50 Index
N° of holdings	60	335
Asset class	Equities	-
Trailing 12m distribution yield	Join	Join
Inception date	November 1, 2006	October 21, 2013
ESG	No	No

More RSPH data on Trackinsight

More FHLC data on Trackinsight

Exposure

Countries

RSPH

USA

96.84%

Other

3.16%

FHLC

USA

97.27%

Other

2.73%

Sectors

RSPH

Healthcare

98.51%

Other

1.49%

FHLC

Healthcare

98.3%

Other

1.7%

Diversification

RSPH

Total weight of top 15 holdings out of 15

28.14%

FHLC

Total weight of top 15 holdings out of 15

61.34%

Top 15 holdings

Data as of September 30, 2026

RSPH

Moderna, Inc.

2.35%

Illumina, Inc.

2.14%

Revvity, Inc.

1.97%

Agilent Technologies, Inc.

1.96%

Mettler-Toledo International, Inc.

1.94%

Intuitive Surgical, Inc.

1.90%

Thermo Fisher Scientific, Inc.

1.81%

West Pharmaceutical Services, Inc.

1.80%

Danaher Corp.

1.79%

Viatris, Inc.

1.79%

Waters Corp.

1.77%

Biogen, Inc.

1.75%

Veeva Systems, Inc.

1.74%

Amgen, Inc.

1.73%

AbbVie, Inc.

1.71%

FHLC

Eli Lilly & Co.

13.09%

Johnson & Johnson

9.02%

AbbVie, Inc.

6.45%

Merck & Co., Inc.

5.08%

UnitedHealth Group, Inc.

4.72%

Thermo Fisher Scientific, Inc.

3.47%

Amgen, Inc.

3.09%

Gilead Sciences, Inc.

2.59%

Abbott Laboratories

2.44%

Pfizer Inc.

2.26%

Intuitive Surgical, Inc.

1.98%

Danaher Corp.

1.98%

Vertex Pharmaceuticals, Inc.

1.85%

Bristol Myers Squibb Co.

1.77%

CVS Health Corp.

1.57%

Frequently asked questions about RSPH and FHLC

How have the RSPH and FHLC ETFs performed in 2026?

As of November 2, 2026, RSPH is up 26.01% year-to-date (YTD), while FHLC has returned 19.89%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: RSPH or FHLC?

Year-to-date, the RSPH ETF saw +$65M in flows, compared to +$495M for FHLC.

Which ETF is more volatile: RSPH or FHLC?

Over the past year, RSPH had a volatility of 16.88%, while FHLC experienced 16.01%.

Which ETF is bigger: RSPH or FHLC?

As of November 2, 2026, RSPH holds $992.08 M in assets under management (AUM), while FHLC manages $3.94 B.

What sectors do the RSPH and FHLC ETFs invest in?

RSPH leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the RSPH ETF and FHLC ETF?

RSPH top holdings include Moderna, Inc., Illumina, Inc. and Revvity, Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: RSPH or FHLC?

RSPH holds 60 securities with 28.14% of its assets in the top 15. FHLC has 335 securities and a top 15 weight of 61.34%.

Tony's ETF Buyers Guide: Equal-Weight ETFs

May 14, 2024

RSPH

RSPHvsFHLCETF Comparison

Invesco S&P 500® Equal Weight Health Care ETF

Fidelity MSCI Health Care Index ETF

RSPH vs FHLC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the RSPH and FHLC ETFs performed in 2026?

As of November 2, 2026, RSPH is up 26.01% year-to-date (YTD), while FHLC has returned 19.89%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: RSPH or FHLC?

Year-to-date, the RSPH ETF saw +$65M in flows, compared to +$495M for FHLC.

Which ETF is more volatile: RSPH or FHLC?

Over the past year, RSPH had a volatility of 16.88%, while FHLC experienced 16.01%.

Which ETF is bigger: RSPH or FHLC?

As of November 2, 2026, RSPH holds $992.08 M in assets under management (AUM), while FHLC manages $3.94 B.

What sectors do the RSPH and FHLC ETFs invest in?

RSPH leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the RSPH ETF and FHLC ETF?

RSPH top holdings include Moderna, Inc., Illumina, Inc. and Revvity, Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: RSPH or FHLC?

RSPH holds 60 securities with 28.14% of its assets in the top 15. FHLC has 335 securities and a top 15 weight of 61.34%.

Tony's ETF Buyers Guide: Equal-Weight ETFs

ETFs’ Next Act: From Access to Selection